New certainty in prostate cancer assessment

The impact of prostate cancer

The impact of prostate cancer

1,000,000 men undergo prostate biopsy each year in the U.S.2
1 out of 6 men will develop prostate cancer during lifetime1
20%3 of all cases are missed by transrectal ultrasound-guided biopsy
Biopsies result in 6.9% hospitalization rate due to complications such as inflammation4

Experience the difference

Today, conventional diagnosis of prostate cancer is done via transrectal ultrasound-guided biopsy. This is not only a painful invasive procedure, it is also “blind” and misses cancer in up to 20% of all cases.5 Many patients have to undergo this highly inconvenient procedure a second time or more. As a result, the final diagnosis and start of treatment may take two years or longer.

MRI is currently the most sensitive technique to diagnose prostate cancer.6 However, Prostate MRI is generally thought to be a time-consuming approach which is predominantly performed in some academic centers and requires the application of endorectal coils. Therefore, it still is a blind spot for many.

»We routinely perform Prostate MRI without the use of an endorectal coil with each of our Tim 4G systems. Day by day.« Leonardo K. Bittencourt, MD, Radiologist
Partner at Carlos Bittencourt, Diagnóstico por Imagem, Rio de Janeiro Area, Brazil

Realize the outcomes

Test your knowledge

Diagnose with certainty

At what percentage can prostate cancer be excluded when examining with MRI?

Slide to your suggested value

MRI can exclude life-threatening prostate tumors with more than 89%7 certainty.

Reduce the need for biopsies

In how many cases can a prostate MRI exam reduce the need for a biopsy in patients suspected with prostate cancer?

Slide to your suggested value

MRI has shown to reduce the need for transrectal biopsy in patients with suspected prostate cancer by 51%8.

Financial value out of a payers' perspective*

Hear from the expert

»Thanks to the latest MRI technology, we can clarify whether a patient simply has an enlarged or chronically inflamed prostate, or a serious case of prostate cancer that could result in death if it is not optimally treated.« Professor Jelle Barentsz
Radboud University, Nijmegen Medical Center, Nijmegen, Netherlands

Accelerate accuracy

Combine trendsetting applications and high-density coils.

New certainty in prostate cancer assessment

Learn more about SEEit* – accelerate accuracy